In the field of obesity, efforts are underway to use multi-omics and clinical data to predict individual responses to weight-loss interventions (including GLP-1RAs) and to precisely predict the risk of side effects (e.g., nausea) using algorithms like Phenomix GRS
Other states, including Florida, Georgia, and Tennessee, generally exclude GLP-1 weight loss shots from Medicaid coverage
The most common side effects are mild and transient, including temporary bloating, gas, or changes in bowel habits during the first few days of supplementation
Compound Stability: Some compounds are inherently more stable in one form than another
With the right help and strategies, people with CVS can handle their symptoms better